L-茶氨酸认知与情感效应的系统综述与荟萃分析
该系统综述与荟萃分析纳入31项随机对照试验(n=1168),比较口服L-茶氨酸与安慰剂在健康及临床人群中的效果。单次200 mg剂量在认知测试前30-60分钟服用可显著改善选择反应时(SMD=0.51;95%CI 0.25-0.77),急性应激降低幅度较小(SMD=0.31)且受高偏倚风险研究影响;单次剂量后抑郁症状显著降低(排除一个离群值后SMD=0.69;95%CI 0.13-1.25),但焦虑效应不一致。L-茶氨酸安全性良好,无严重不良事件报告。
要点
- 单次200 mg L-茶氨酸在认知测试前30-60分钟服用可改善健康成人选择反应时。
- 急性应激降低效应较小且受高偏倚风险研究影响,疲劳无显著改善。
- 单次剂量后抑郁症状降低(排除离群值后SMD=0.69),需高质量试验验证。
核心结论
- L-茶氨酸安全性良好,对健康成人注意力有稳健的短期益处,潜在抗抑郁效应需高质量试验确认。
研究设计与样本
- 系统综述与荟萃分析纳入31项随机对照试验,共1168名健康及临床人群受试者,比较口服L-茶氨酸与安慰剂。
主要发现
- 单次200 mg剂量在认知测试前30-60分钟服用显著改善选择反应时(SMD=0.51;95%CI 0.25-0.77)。
- 急性应激降低幅度较小(SMD=0.31),且主要受高偏倚风险研究影响。
- 排除一个离群值后,单次剂量在健康个体中显著降低抑郁症状(SMD=0.69;95%CI 0.13-1.25),异质性低。
- 焦虑效应不一致且无统计学显著性,仅一项精神病性焦虑研究显示效应(SMD=0.54;400 mg/天持续8周)。
- 未报告严重不良事件,疲劳无显著效应。
关键数值与推荐
- 单次200 mg L-茶氨酸在认知测试前30-60分钟服用改善选择反应时(SMD=0.51;95%CI 0.25-0.77)。
- 急性应激降低SMD=0.31,受高偏倚风险研究影响。
- 排除离群值后单次剂量降低抑郁症状SMD=0.69(95%CI 0.13-1.25),异质性低。
- 精神病性焦虑研究显示SMD=0.54(400 mg/天持续8周)。
临床怎么用
- 健康成人短期注意力改善可考虑单次200 mg L-茶氨酸在认知任务前30-60分钟使用。
- 抑郁症状的潜在益处证据尚不充分,需高质量试验验证后再用于临床决策。
- 焦虑相关效应不一致,仅精神病性焦虑有初步证据,不应作为常规推荐。
局限性
- 急性应激效应主要受高偏倚风险研究影响,结果稳健性有限。
- 抑郁症状效应在排除一个离群值后显著,需高质量试验确认。
- 焦虑效应不一致且多数无统计学显著性,证据强度不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: L-theanine, an amino acid derived from green tea, has been suggested to alleviate affective symptoms and enhance cognitive performance, but its clinical relevance remains uncertain. METHODS: We conducted a systematic review and meta-analysis of 31 randomised controlled trials (n = 1168) comparing oral L-theanine with placebo in healthy and clinical populations. The primary outcome was the acute effect of a single dose on stress in healthy adults. Secondary outcomes included clinical measures (stress after repeated dosing, anxiety, depressive symptoms, and fatigue) and cognitive measures (reaction times and attention tasks with single and repeated doses). Safety was assessed by comparing dropout rates and reasons between L-theanine and placebo groups. RESULTS: A single 200 mg dose taken 30-60 min before cognitive testing significantly improved choice reaction time (Standardised Mean Difference [SMD] = 0.51; 95% CI, 0.25-0.77), indicating enhanced attention. The reduction in acute stress was modest (SMD = 0.31) and largely influenced by studies with a high risk of bias. No significant effect on fatigue was observed. Excluding one outlier, a significant reduction in depressive symptoms following a single dose in healthy individuals was found (SMD = 0.69; 95% CI, 0.13-1.25) with low heterogeneity. Anxiety effects were inconsistent and non-significant except for one study on psychotic anxiety (SMD = 0.54; 400 mg/day for 8 weeks). No serious adverse events were reported. CONCLUSIONS: L-theanine is safe and shows a robust short-term benefit on attention in healthy adults, with a potential antidepressant effect warranting confirmation in high-quality trials, especially in clinical populations.
引用
- Gerolymos C, Saddier E, Boyer L, et al. Cognitive and affective effects of L-Theanine: a systematic review and meta-analysis of 31 randomized trials. Mol Psychiatry. 2026. PMID: 42410082. doi:10.1038/s41380-026-03727-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。